Atea Pharmaceuticals (AVIR)
(Delayed Data from NSDQ)
$3.69 USD
-0.01 (-0.27%)
Updated Apr 25, 2024 04:00 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/13/24 |
---|---|
Current Quarter | -0.61 |
EPS Last Quarter | -0.47 |
Last EPS Surprise | -6.82% |
ABR | 3.17 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.76 |
Next Year | -2.92 |
EPS (TTM) | -1.64 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 40.87M |
# of Estimates | NA | NA | NA | 4 |
High Estimate | NA | NA | NA | 76.47M |
Low Estimate | NA | NA | NA | 1.51M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.61 | -0.68 | -2.76 | -2.92 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -0.63 | -0.68 | -2.50 | -3.13 |
High Estimate | -0.57 | -0.62 | -2.50 | -2.50 |
Low Estimate | -0.63 | -0.75 | -3.03 | -3.14 |
Year ago EPS | -0.43 | -0.34 | -1.63 | -2.76 |
Year over Year Growth Est. | -41.86% | -100.00% | -69.33% | -5.92% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.61 | -0.68 | -2.76 | -2.92 |
7 Days Ago | -0.61 | -0.68 | -2.76 | -2.92 |
30 Days Ago | -0.61 | -0.68 | -2.76 | -2.92 |
60 Days Ago | -0.63 | -0.69 | -2.82 | -2.82 |
90 Days Ago | -0.62 | -0.70 | -2.82 | -2.77 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.61 | -0.68 | -2.76 | -2.92 |
Zacks Consensus Estimate | -0.61 | -0.68 | -2.76 | -2.92 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.47 | -0.40 | -0.34 | -0.43 | NA |
Estimate | -0.44 | -0.46 | -0.47 | -0.51 | NA |
Difference | -0.03 | 0.06 | 0.13 | 0.08 | 0.06 |
Surprise | -6.82% | 13.04% | 27.66% | 15.69% | 12.39% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more